Citius Pharmaceuticals, Inc. (CTXR)
$0.50+2.04%Close
SELLCRISIS · day 10
Key stats
Short interest · FINRA settlement 2026-09-30
- Market cap
- $6M
- Beta
- 1.00
- P/E (TTM)
- -0.23
- Short % float
- 53.06%
- Days to cover
- 30.5
- SI change
- +0.5%
- 1W
- -5.66%
- 1M
- -15.25%
- vs SPY 1W
- -6.82%
- vs SPY 1M
- -18.25%
Prediction markets
Kalshi · Polymarket · … linked
Loading markets…
Company news
FAQ
- What is LOPJLB’s current signal on CTXR?
- LOPJLB’s latest quantitative signal on Citius Pharmaceuticals, Inc. (CTXR) is SELL in a CRISIS regime. Signals are updated daily.
- What market regime is CTXR in?
- Citius Pharmaceuticals, Inc. (CTXR) is currently classified in the CRISIS HMM market regime on LOPJLB.
- What does Citius Pharmaceuticals, Inc. (CTXR) do?
- Citius Pharmaceuticals, Inc. operates as a specialized pharmaceutical firm concentrating on the development and market introduction of critical care products. Its efforts are particularly directed towards anti-infective treatments supporting cancer care, various prescription medications, and pioneering mesenchymal stem cell therapies. The company is actively advancing five unique products withi…